These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36436108)

  • 1. Seven classes of antiviral agents.
    Ianevski A; Ahmad S; Anunnitipat K; Oksenych V; Zusinaite E; Tenson T; Bjørås M; Kainov DE
    Cell Mol Life Sci; 2022 Nov; 79(12):605. PubMed ID: 36436108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and development of safe-in-man broad-spectrum antiviral agents.
    Andersen PI; Ianevski A; Lysvand H; Vitkauskiene A; Oksenych V; Bjørås M; Telling K; Lutsar I; Dumpis U; Irie Y; Tenson T; Kantele A; Kainov DE
    Int J Infect Dis; 2020 Apr; 93():268-276. PubMed ID: 32081774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs.
    Tompa DR; Immanuel A; Srikanth S; Kadhirvel S
    Int J Biol Macromol; 2021 Mar; 172():524-541. PubMed ID: 33454328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
    Mercorelli B; Palù G; Loregian A
    Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-spectrum Respiratory Virus Entry Inhibitors.
    Zhao H; Yuen KY
    Adv Exp Med Biol; 2022; 1366():137-153. PubMed ID: 35412139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferons and their use in persistent viral infections.
    Chevaliez S; Pawlotsky JM
    Handb Exp Pharmacol; 2009; 189(189):203-41. PubMed ID: 19048202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.
    Ray B; Ali I; Jana S; Mukherjee S; Pal S; Ray S; Schütz M; Marschall M
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safe-in-Man Broad Spectrum Antiviral Agents.
    Yao R; Ianevski A; Kainov D
    Adv Exp Med Biol; 2021; 1322():313-337. PubMed ID: 34258746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity.
    Zelikin AN; Stellacci F
    Adv Healthc Mater; 2021 Mar; 10(6):e2001433. PubMed ID: 33491915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivirals and antiviral strategies.
    De Clercq E
    Nat Rev Microbiol; 2004 Sep; 2(9):704-20. PubMed ID: 15372081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.
    Zhang M; Zhong J; Xiong Y; Song X; Li C; He Z
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34203182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Antiviral Action of Alkaloids.
    Abookleesh FL; Al-Anzi BS; Ullah A
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems.
    Brezgin S; Kostyusheva A; Bayurova E; Volchkova E; Gegechkori V; Gordeychuk I; Glebe D; Kostyushev D; Chulanov V
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Garrod lecture 1984. Strategies of antiviral chemotherapy.
    Stuart-Harris C
    J Antimicrob Chemother; 1985 Apr; 15(4):387-97. PubMed ID: 2409067
    [No Abstract]   [Full Text] [Related]  

  • 16. Intervention strategies for emerging viruses: use of antivirals.
    Debing Y; Jochmans D; Neyts J
    Curr Opin Virol; 2013 Apr; 3(2):217-24. PubMed ID: 23562753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acid-based drugs against emerging zoonotic viruses.
    Wong JP
    Future Med Chem; 2015; 7(13):1709-19. PubMed ID: 26399689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drugs in pediatrics.
    Balfour HH; Englund JA
    Am J Dis Child; 1989 Nov; 143(11):1307-16. PubMed ID: 2554721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel activities of safe-in-human broad-spectrum antiviral agents.
    Ianevski A; Zusinaite E; Kuivanen S; Strand M; Lysvand H; Teppor M; Kakkola L; Paavilainen H; Laajala M; Kallio-Kokko H; Valkonen M; Kantele A; Telling K; Lutsar I; Letjuka P; Metelitsa N; Oksenych V; Bjørås M; Nordbø SA; Dumpis U; Vitkauskiene A; Öhrmalm C; Bondeson K; Bergqvist A; Aittokallio T; Cox RJ; Evander M; Hukkanen V; Marjomaki V; Julkunen I; Vapalahti O; Tenson T; Merits A; Kainov D
    Antiviral Res; 2018 Jun; 154():174-182. PubMed ID: 29698664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.